Infant Ibuprofen Recall 2018: What Parents Should Know

The drug could cause permanent kidney injury

By Karl Utermohlen, InvestorPlace Writer

http://bit.ly/2Pna7fW

An infant ibuprofen recall was issued as there are concerns regarding the dosage listed on the bottle compared to how much ibuprofen is actually on each pill.

Infant Ibuprofen Recall
Source: Flickr

There are three lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, which are sold in 0.5 oz. bottles, that were mentioned in the recall. These can be found at Wal-Mart, CVS Pharmacy and Family Dollar Services and they may reportedly have higher concentrations of ibuprofen than what’s printed on the label.

Parents should act swiftly to return or throw out the product as there is a possibility that infants who take the drug could be more susceptible to permanent kidney injury caused by a nonsteroidal anti-inflammatory drug, also known as an NSAID.

The medication could also cause babies to experience other symptoms, including nausea, vomiting, abdominal pain or diarrhea. Other possible adverse effects include tinnitus, headache and gastrointestinal bleeding.

Here are the three products included in the recall:

  • Equate: This is an Infants’ Ibuprofen Concentrated Oral Suspension sold at Walmart. Its expiration dates are of February 2019, April 2019 and August 2019. The lot numbers: 00717009A, 00717015A, 00717024A. NDC number 49035-125-23
  • CVS Health: Infants’ Ibuprofen Concentrated Oral Suspension that is sold at CVS Pharmacy and with the expiration date of August 2019. Lot number: 00717024A. NDC number: 59779-925-23
  • Family Wellness: Infants’ Ibuprofen Concentrated Oral Suspension that comes with the expiration date of August 2019. Lot number: 00717024A. NDC number: 55319-250-23.

Article printed from InvestorPlace Media, https://investorplace.com/2018/12/infant-ibuprofen-recall/.

©2018 InvestorPlace Media, LLC